SELLAS Life Sciences Gr Analyst Ratings
SELLAS Life Sciences Gr Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/07/2023 | 110.53% | Cantor Fitzgerald | → $3 | Reiterates | Overweight → Overweight |
| 11/15/2022 | 461.4% | Alliance Global Partners | $14 → $8 | Maintains | Buy |
| 06/28/2022 | 321.05% | Cantor Fitzgerald | $10 → $6 | Maintains | Overweight |
| 07/21/2021 | 1163.16% | Cantor Fitzgerald | → $18 | Initiates Coverage On | → Overweight |
| 11/15/2019 | 742.11% | Maxim Group | → $12 | Upgrades | Hold → Buy |
| 04/08/2019 | 215.79% | Alliance Global Partners | → $4.5 | Initiates Coverage On | → Buy |
| 11/01/2018 | 812.28% | Oppenheimer | → $13 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 09/07/2023 | 110.53% | 康托·菲茨杰拉德 | →$3 | 重申 | 超重→超重 |
| 2022年11月15日 | 461.4% | 联盟全球合作伙伴 | $14→$8 | 维护 | 买 |
| 2022/06/28 | 321.05% | 康托·菲茨杰拉德 | $10→$6 | 维护 | 超重 |
| 07/21/2021 | 1163.16% | 康托·菲茨杰拉德 | →$18 | 开始承保 | →超重 |
| 2019年11月15日 | 742.11% | Maxim集团 | →$12 | 升级 | 持有→购买 |
| 2019年08月04日 | 215.79% | 联盟全球合作伙伴 | →$4.5 | 开始承保 | →购买 |
| 2018/11/01 | 812.28% | 奥本海默 | →$13 | 开始承保 | →跑赢大盘 |
What is the target price for SELLAS Life Sciences Gr (SLS)?
Sellas Life Science Gr(SLS)的目标价是多少？
The latest price target for SELLAS Life Sciences Gr (NASDAQ: SLS) was reported by Cantor Fitzgerald on September 7, 2023. The analyst firm set a price target for $3.00 expecting SLS to rise to within 12 months (a possible 110.53% upside). 2 analyst firms have reported ratings in the last year.
坎托·菲茨杰拉德于2023年9月7日报道了塞拉斯生命科学公司(纳斯达克：SLS)的最新目标价。这家分析公司将目标价定为3美元，预计SLS将在12个月内升至(可能上涨110.53%)。去年有两家分析公司公布了评级。
What is the most recent analyst rating for SELLAS Life Sciences Gr (SLS)?
Sellas Life Science Gr(SLS)的最新分析师评级是多少？
The latest analyst rating for SELLAS Life Sciences Gr (NASDAQ: SLS) was provided by Cantor Fitzgerald, and SELLAS Life Sciences Gr reiterated their overweight rating.
赛拉斯生命科学Gr(纳斯达克代码：SLS)的最新分析师评级由康托·菲茨杰拉德提供，赛拉斯生命科学Gr重申其增持评级。
When is the next analyst rating going to be posted or updated for SELLAS Life Sciences Gr (SLS)?
Sellas Life Science Gr(SLS)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SELLAS Life Sciences Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SELLAS Life Sciences Gr was filed on September 7, 2023 so you should expect the next rating to be made available sometime around September 7, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Sellas Life Science Gr的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Sellas Life Science Gr的上一次评级是在2023年9月7日提交的，所以你应该预计下一次评级将在2024年9月7日左右的某个时候提供。
Is the Analyst Rating SELLAS Life Sciences Gr (SLS) correct?
分析师对Sellas Life Science Gr(SLS)的评级正确吗？
While ratings are subjective and will change, the latest SELLAS Life Sciences Gr (SLS) rating was a reiterated with a price target of $0.00 to $3.00. The current price SELLAS Life Sciences Gr (SLS) is trading at is $1.43, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Sellas Life Science Gr(SLS)评级被重申，目标价在0.00美元至3.00美元之间。Sellas Life Science Gr(SLS)目前的交易价格为1.43美元，在分析师的预测范围内。